CARL
Carlsmed, Inc.
14.80$
+0.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 28.0% | 28.0% | 25.0% | 27.2% | 25.3% | 25.1% | 26.6% | 24.1% | 23.5% | 22.9% | 23.2% | 23.4% | |
| 72.0% | 72.0% | 75.0% | 72.8% | 74.7% | 74.9% | 73.4% | 75.9% | 76.5% | 77.1% | 76.8% | 76.6% | |
| – | 64.0% | 65.7% | 61.2% | 32.0% | 30.9% | 34.4% | 34.0% | 34.7% | 32.1% | 31.9% | 33.1% | |
| – | 42.1% | 33.1% | 29.1% | 24.7% | 34.0% | 27.7% | 37.5% | 32.0% | 38.6% | 40.2% | 37.3% | |
| 197.3% | 176.8% | 178.9% | -45.2% | 537.5% | 131.1% | 127.2% | 145.0% | 138.0% | 134.7% | 135.0% | 137.7% | |
| -125.3% | -104.8% | -103.9% | 118.0% | -462.9% | -56.1% | -53.8% | -69.1% | -61.4% | -57.6% | -58.3% | -61.1% | |
| – | 4.2% | 5.3% | 6.1% | 4.0% | 3.5% | 3.0% | 2.9% | 2.2% | 1.9% | 1.7% | 2.1% | |
| -127.7% | -107.1% | -103.2% | -118.6% | -50.2% | -56.2% | -56.0% | -65.2% | -56.8% | -54.0% | -55.5% | -57.4% | |
| -127.7% | -107.1% | -103.2% | -118.6% | -50.2% | -56.2% | -56.0% | -65.2% | -56.8% | -54.0% | -55.5% | -57.4% | |
| -127.7% | -104.0% | -103.3% | -112.0% | -45.8% | -52.3% | -52.5% | -61.7% | -54.0% | -51.4% | 1.7% | -38.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.